According to Oragenics's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -S$16.52 Million, an increase over its 2021 earnings that were of -S$21.01 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -S$12.3 Million | |
2022 | -S$16.52 Million | -21.39% |
2021 | -S$21.01 Million | -40.59% |
2020 | -S$35.37 Million | 69.81% |
2019 | -S$20.83 Million | 57.03% |
2018 | -S$13.27 Million | 52.08% |
2017 | -S$8.73 Million | -23.29% |
2016 | -S$11.37 Million | -27.32% |
2015 | -S$15.65 Million | 101.97% |
2014 | -S$7.75 Million | -63.96% |
2013 | -S$21.49 Million | 29.08% |
2012 | -S$16.65 Million | |
2010 | -S$11.39 Million | 55.35% |
2009 | -S$7.33 Million | -8.93% |
2008 | -S$8.05 Million | 157.51% |
2007 | -S$3.13 Million | -21.18% |
2006 | -S$3.97 Million | 96.69% |
2005 | -S$2.02 Million | -26.03% |
2004 | -S$2.73 Million | 22.06% |
2003 | -S$2.24 Million |